RESEARCH

Funded Research Projects

Funded Research Projects

Funded Research Projects

Since the creation of the Quebec Research Fund on Parkinson in 2012, Parkinson Québec has contributed to the financing of a number of research projects.

Projects financed in association with the National Research Program of Parkinson Society Canada

Ongoing

Mr. Alexandru Hanganu
Institut Universitaire de Gériatrie de Montréal
Evolution of mild cognitive impairment in patients with Parkinson’s disease
2014-2016 ($80,000, of which the QRFP’s contribution: $30,000/2 years)

Mr. Omid Tavassoly
McGill University
Molecular Mechanism of Alpha-Synuclein Propagation in Parkinson’s disease
2014-2016 ($80,000, of which the QRFP’s contribution: $30,000/2 years)

Mr. Nadhir Litim
Université Laval
Effects of Gonadial Drugs as Neuroprotectors in Animal Models of Parkinson’s Disease
2014-2017 (60,000, of which the QRFP’s contribution: $30,000/3 years)

Dr. Siegfried Hekimi
McGill University
A ground-breaking screen for drugs that target mitochondrial dysfunction in Parkinson’s disease
2015-2016 ($45,000/1 year)

Dr. Jacques Montplaisir
Université de Montréal
Cholinergic PET imaging as a prodromal marker of PD in REM sleep behaviour disorder
2015-2016 ($44,850/1 year)

Pr. Louis-Eric Trudeau, PhD
Université de Montréal
Dopamine neuron axonal arborization size as a target to influence vulnerability and produce better mouse models of Parkinson’s disease
2015-2016 ($44,240/1 year)

M. Charles Ducrot
Université de Montréal
Survival of Dopamine Neurons in Parkinson’s Disease: The Role of Synaptic Contacts
2015-2017 ($30,000, of which the QRFP’s contribution: $15,000/2 years)

M. Stefano Cataldi
University of British-Columbia
Quebec Research Fund on Parkinson
2016-2018 (30 000$, of wich the QRFP’s contribution: 15 000$/2 years)

Previous

Pr. Alex MacKay
University of British Columbia
Assessment of “normal appearing” white matter in Parkinson’s disease and its association with cognitive dysfunction
2014-2015 ($45,000/1 year)

Pr. Pascale Legault
Université de Montréal
Bio-genesis of microRNA’s associated with Parkinson’s disease
2013-2015 ($45,000/1 year)

Mr. Martin Duennwald
University of Western Ontario
Identification of parkin substrates in early-onset Parkinson’s disease
2013-2015 ($45,000/1 year)

Pr. Brian Staveley
Memorial University
The Pink1-parkin-Paris-Pgc-1a pathway in Drosophila models of Parkinson disease
2012-2014 ($45,000/1 year)

Pr. Jeremy Lee, PhD
University of Saskatchewan
Understanding the misfolding of alpha-synuclein
2012-2014 ($44,100/1year)

Pr. Louis-Éric Trudeau, PhD
Université de Montréal
Evaluating axonal arbor size as a vulnerability factor in Parkinson’s disease
2012-2014 ($45,000/1 year)

Pr. David Stellwagen, PhD
McGill University
TNFalpha mediated synaptic plasticity in Parkinson’s disease and levodopa-induced dyskinesia
2012-2014 ($90,000/2 years)

Dr. Joanne Lemieux, PhD
University of Alberta
In vitro functional and structural study of PINK1 cleavage in Parkinson’s disease
2012-2014 ($90,000/2 years)

Dr. Frédéric Calon
Université Laval
Can exercice and omega-3 fatty acids synergize to restore dopamine neurons in Parkinson’s disease?
2014-2016 ($45,000/1 year)

Dr. Francesca Cicchetti
Université Laval
Microvesicles : biomarkers and vehicles for the propagation of alpha synuclein
2014-2016 ($45,000/1 year)

Dr. Julien Doyon
Institut de gériatrie de Montréal
Effects of aerobic exercise training with or without preferred rhythms on learning new motor skills in patients with Parkinson’s disease
2014-2016 ($44,725/1 year)

Dr. Ronald Postuma
McGill University
Association of cognitive impairment and orthostatic hypotension in patients suffering from Parkinson’s disease
2014-2016 ($40,620/1 year)

Mrs. Jessica Trung
McGill University
Cognitive Impairment and Parkinson’s
2014-2017 (60,000, of which the QRFP’s contribution: $30,000/3 years)

Projects financed in association with the Fonds de recherche québécois - Santé

Ongoing

Mr. Dave Gagnon
Université Laval
Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia
2014-2017 ($60,000, of which the QRFP’s contribution: $30,000/3 years)

Mrs. Marjan Seirafi
McGill University
Structural studies of the activated form of the parkin protein
2014-2017 ($60,000, of which the QRFP’s contribution: $30,000/3 years)

Dr. Ronald Postuma
McGill University
1-REM sleep behavior disorder on Prodromal Parkinson’s Disease
2- Caffeine for Parkinson’s Disease
2014-2018 ($126,557, of which the QRFP’s contribution: $25,000/4 years)

Mr. Clifford Cassidy
New York State Psychiatric Institute
Neuromelanine-sensible MRI : une méthode nouvelle et non-invasive pour imager les neurones dopamines fournissant un biomarqueur possible de la maladie de Parkinson
2015-2016 ($45,000, of which the QRFP’s contribution: $15,000/1 year)

Mrs. Andrée-Anne Poirier
Centre de recherche du CHU de Québec
Study of the neuroprotective and anti-inflammatory effects of gonadal hormone modulator treatments on the enteric nervous system in parkinson’s disease
2015-2017 ($30,000, of which the QRFP’s contribution: $10,000/2 years)

Mme Julie Renaud
Université du Québec à Trois-Rivières
Rôle neuroprotecteur du resvératrol dans un modèle de rat
chroniquement hyperglycémique : étude de la neurodégnérescence dopaminergique, du comportement et des paramètres neurométaboliques
2016-2018 ($40,000, of wich the QRFP’s contribution: $20,000/2 years)

Mme Cécilia Tremblay
Université du Québec à Trois-Rivières
Caractérisation de la performance chimiosensorielle dans la maladie de Parkinson
2016-2019 ($60,000, of wich the QRFP’s contribution: $20,000/2 years)

M. Dymka Coudé
Institut universitaire en santé mentale de Québec
Étude neuronale des projections dopaminergiques chez le singe
2016-2018 ($30,000, of wich the QRFP’s contribution: $10,000/2 years)

Dr. Philippe Huot
Centre de recherche du CHUM
Étude de la neuropharmacologie des ganglions de la base
2016-2020 ($139,121, of wich the QRFP’s contribution $40,000/2 years)

Previous

Mrs. Hélène Doucet-Beaupré
Université Laval
The role of developmental transcription factors in adult midbrain dopaminergic neurons
2014-2015 ($30,000, of which the QRFP’s contribution: $15,000/1 year)

Visitez notre >> Centre info Parkinson

Simple Share Buttons